Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calmodulin binding	CACNA1C CACNA1S MYH2 MYH3 SPTAN1 RYR2 STRN TRPV4 PNCK SNTB2 PCNT	3.89e-06	230	167	11	GO:0005516
GeneOntologyMolecularFunction	actin binding	MYH2 MYH3 FLNC SHROOM3 INPPL1 SPTAN1 KLHL20 ANLN CLMN DAAM2 TRPV4 DAAM1 NEXN UTRN SNTB2	1.26e-05	479	167	15	GO:0003779
GeneOntologyMolecularFunction	cytoskeletal protein binding	TPR CACNA1C MYH2 MYH3 FLNC SHROOM3 INPPL1 SPTAN1 NUMA1 KLHL20 SETD2 TIAM1 LMO7 ANLN CLMN DAAM2 TRPV4 DAAM1 KIF13A NEXN UTRN SNTB2 MAPK8IP2 NIN	1.53e-05	1099	167	24	GO:0008092
GeneOntologyCellularComponent	cortical cytoskeleton	MYH2 SHROOM3 SPTAN1 NUMA1 ANLN TRPV4 BSN	7.79e-05	129	166	7	GO:0030863
GeneOntologyCellularComponent	synaptic cleft	ADGRB3 LAMA5 AGRN CDH8	1.31e-04	33	166	4	GO:0043083
GeneOntologyCellularComponent	contractile ring	MYH2 ANLN UTRN	1.68e-04	14	166	3	GO:0070938
GeneOntologyCellularComponent	sarcomere	CACNA1C CACNA1S MYH2 MYH3 FLNC SPTAN1 MYOM3 RYR2 NEXN	1.75e-04	249	166	9	GO:0030017
GeneOntologyCellularComponent	synaptic membrane	CACNA1C PCDHB13 PCDHB8 ADGRB3 RPH3A CNTN6 STRN LRFN4 CLCN3 TIAM1 KCNJ9 BSN UTRN CDH8	2.39e-04	583	166	14	GO:0097060
GeneOntologyCellularComponent	cell-cell junction	MYH2 SHROOM3 EPPK1 SPTAN1 LAMA3 STRN TIAM1 LMO7 TRPV4 TNKS1BP1 NEXN PCDH1 CDH8 SYMPK	2.74e-04	591	166	14	GO:0005911
GeneOntologyCellularComponent	myofibril	CACNA1C CACNA1S MYH2 MYH3 FLNC SPTAN1 MYOM3 RYR2 NEXN	3.44e-04	273	166	9	GO:0030016
GeneOntologyCellularComponent	laminin-5 complex	LAMA3 LAMA5	3.72e-04	4	166	2	GO:0005610
GeneOntologyCellularComponent	dendrite	CABP1 CACNA1C CACNA1S PSD NUMA1 PEX5L RPH3A KLHL20 USP8 STRN TIAM1 RAB3IP SKOR1 GIGYF2 MCRS1 BSN NIN	4.93e-04	858	166	17	GO:0030425
GeneOntologyCellularComponent	dendritic tree	CABP1 CACNA1C CACNA1S PSD NUMA1 PEX5L RPH3A KLHL20 USP8 STRN TIAM1 RAB3IP SKOR1 GIGYF2 MCRS1 BSN NIN	5.06e-04	860	166	17	GO:0097447
GeneOntologyCellularComponent	contractile muscle fiber	CACNA1C CACNA1S MYH2 MYH3 FLNC SPTAN1 MYOM3 RYR2 NEXN	5.33e-04	290	166	9	GO:0043292
GeneOntologyCellularComponent	cell cortex	CABP1 MYH2 SHROOM3 SPTAN1 NUMA1 STIL C2CD2L ANLN TRPV4 BSN	7.89e-04	371	166	10	GO:0005938
GeneOntologyCellularComponent	cortical actin cytoskeleton	MYH2 SHROOM3 SPTAN1 ANLN TRPV4	8.80e-04	93	166	5	GO:0030864
GeneOntologyCellularComponent	supramolecular fiber	CACNA1C CACNA1S MYH2 MYH3 FLNC SHROOM3 EPPK1 SPTAN1 NUMA1 MYOM3 AKNA RYR2 TIAM1 TRPV4 NME7 KIF13A NEXN SNTB2 PCNT NIN	1.11e-03	1179	166	20	GO:0099512
GeneOntologyCellularComponent	photoreceptor disc membrane	ABCA4 PCDHB13 PCDHB8	1.12e-03	26	166	3	GO:0097381
GeneOntologyCellularComponent	supramolecular polymer	CACNA1C CACNA1S MYH2 MYH3 FLNC SHROOM3 EPPK1 SPTAN1 NUMA1 MYOM3 AKNA RYR2 TIAM1 TRPV4 NME7 KIF13A NEXN SNTB2 PCNT NIN	1.20e-03	1187	166	20	GO:0099081
GeneOntologyCellularComponent	actomyosin contractile ring	MYH2 ANLN	1.28e-03	7	166	2	GO:0005826
GeneOntologyCellularComponent	pericentriolar material	TIAM1 PCNT NIN	1.39e-03	28	166	3	GO:0000242
GeneOntologyCellularComponent	postsynaptic membrane	CACNA1C PCDHB13 PCDHB8 ADGRB3 RPH3A STRN LRFN4 CLCN3 TIAM1 UTRN	1.52e-03	405	166	10	GO:0045211
GeneOntologyCellularComponent	adherens junction	SHROOM3 LAMA3 LMO7 TRPV4 TNKS1BP1 NEXN CDH8	1.56e-03	212	166	7	GO:0005912
GeneOntologyCellularComponent	anchoring junction	MYH2 FLNC SHROOM3 EPPK1 SPTAN1 LAMA3 STRN TIAM1 LMO7 CSPG4 TRPV4 TNKS1BP1 NEXN PCDH1 CDH8 SNTB2 SYMPK	2.00e-03	976	166	17	GO:0070161
GeneOntologyCellularComponent	I band	CACNA1C CACNA1S FLNC SPTAN1 RYR2 NEXN	2.14e-03	166	166	6	GO:0031674
GeneOntologyCellularComponent	extrinsic component of membrane	CABP1 RPH3A RYR2 TIAM1 SLA2 BSN CDH8	2.47e-03	230	166	7	GO:0019898
Domain	LAM_G_DOMAIN	LAMA3 LAMA5 CELSR1 CSPG4 AGRN	2.01e-05	38	165	5	PS50025
Domain	LamG	LAMA3 LAMA5 CELSR1 CSPG4 AGRN	4.16e-05	44	165	5	SM00282
Domain	FAM21	WASHC2C WASHC2A	7.76e-05	2	165	2	IPR027308
Domain	FHA	AGGF1 MKI67 MCRS1 KIF13A	1.02e-04	28	165	4	SM00240
Domain	EGF_LAM_2	LAMA3 LAMA5 CELSR1 AGRN	1.35e-04	30	165	4	PS50027
Domain	EGF_LAM_1	LAMA3 LAMA5 CELSR1 AGRN	1.35e-04	30	165	4	PS01248
Domain	FHA_DOMAIN	AGGF1 MKI67 MCRS1 KIF13A	1.53e-04	31	165	4	PS50006
Domain	FHA	AGGF1 MKI67 MCRS1 KIF13A	1.53e-04	31	165	4	PF00498
Domain	Laminin_G	LAMA3 LAMA5 CELSR1 CSPG4 AGRN	1.59e-04	58	165	5	IPR001791
Domain	CAP-ZIP_m	WASHC2C WASHC2A	2.31e-04	3	165	2	PF15255
Domain	FAM21/CAPZIP	WASHC2C WASHC2A	2.31e-04	3	165	2	IPR029341
Domain	EGF_Lam	LAMA3 LAMA5 CELSR1 AGRN	2.48e-04	35	165	4	SM00180
Domain	Laminin_EGF	LAMA3 LAMA5 CELSR1 AGRN	2.48e-04	35	165	4	PF00053
Domain	CH	FLNC LRCH2 LMO7 CLMN UTRN	2.73e-04	65	165	5	SM00033
Domain	-	AGGF1 MKI67 MCRS1 KIF13A	2.78e-04	36	165	4	2.60.200.20
Domain	FHA_dom	AGGF1 MKI67 MCRS1 KIF13A	2.78e-04	36	165	4	IPR000253
Domain	Laminin_EGF	LAMA3 LAMA5 CELSR1 AGRN	3.43e-04	38	165	4	IPR002049
Domain	CH	FLNC LRCH2 LMO7 CLMN UTRN	3.86e-04	70	165	5	PF00307
Domain	-	FLNC LRCH2 LMO7 CLMN UTRN	4.12e-04	71	165	5	1.10.418.10
Domain	Cadherin_CS	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1 CDH8	4.15e-04	109	165	6	IPR020894
Domain	Laminin_G_2	LAMA3 LAMA5 CELSR1 CSPG4	4.19e-04	40	165	4	PF02210
Domain	VDCC_L_a1su	CACNA1C CACNA1S	4.60e-04	4	165	2	IPR005446
Domain	CH	FLNC LRCH2 LMO7 CLMN UTRN	4.69e-04	73	165	5	PS50021
Domain	CADHERIN_1	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1 CDH8	5.03e-04	113	165	6	PS00232
Domain	Cadherin	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1 CDH8	5.03e-04	113	165	6	PF00028
Domain	CADHERIN_2	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1 CDH8	5.27e-04	114	165	6	PS50268
Domain	-	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1 CDH8	5.27e-04	114	165	6	2.60.40.60
Domain	CH-domain	FLNC LRCH2 LMO7 CLMN UTRN	5.31e-04	75	165	5	IPR001715
Domain	CA	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1 CDH8	5.52e-04	115	165	6	SM00112
Domain	Cadherin-like	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1 CDH8	5.78e-04	116	165	6	IPR015919
Domain	Cadherin	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1 CDH8	6.33e-04	118	165	6	IPR002126
Domain	Laminin_domII	LAMA3 LAMA5	7.62e-04	5	165	2	IPR010307
Domain	Laminin_aI	LAMA3 LAMA5	7.62e-04	5	165	2	IPR009254
Domain	Laminin_I	LAMA3 LAMA5	7.62e-04	5	165	2	PF06008
Domain	Laminin_II	LAMA3 LAMA5	7.62e-04	5	165	2	PF06009
Domain	WW	FNBP4 PRPF40A SETD2 UTRN	7.79e-04	47	165	4	PF00397
Domain	WW	FNBP4 PRPF40A SETD2 UTRN	8.44e-04	48	165	4	SM00456
Domain	ACTININ_2	FLNC CLMN UTRN	1.05e-03	23	165	3	PS00020
Domain	ACTININ_1	FLNC CLMN UTRN	1.05e-03	23	165	3	PS00019
Domain	Actinin_actin-bd_CS	FLNC CLMN UTRN	1.05e-03	23	165	3	IPR001589
Domain	WW_DOMAIN_1	FNBP4 PRPF40A SETD2 UTRN	1.06e-03	51	165	4	PS01159
Domain	WW_DOMAIN_2	FNBP4 PRPF40A SETD2 UTRN	1.06e-03	51	165	4	PS50020
Domain	WW_dom	FNBP4 PRPF40A SETD2 UTRN	1.14e-03	52	165	4	IPR001202
Domain	SMAD_FHA_domain	AGGF1 MKI67 MCRS1 KIF13A	1.14e-03	52	165	4	IPR008984
Domain	-	LAMA3 LAMA5 CELSR1 CSPG4 AGRN	1.55e-03	95	165	5	2.60.120.200
Domain	Ca_chan_IQ	CACNA1C CACNA1S	1.58e-03	7	165	2	SM01062
Domain	Ca_chan_IQ	CACNA1C CACNA1S	1.58e-03	7	165	2	PF08763
Domain	VDCC_a1su_IQ	CACNA1C CACNA1S	1.58e-03	7	165	2	IPR014873
Domain	GPHH	CACNA1C CACNA1S	1.58e-03	7	165	2	PF16905
Domain	GPHH_dom	CACNA1C CACNA1S	1.58e-03	7	165	2	IPR031649
Domain	DAD_dom	DAAM2 DAAM1	2.10e-03	8	165	2	IPR014767
Domain	DAD	DAAM2 DAAM1	2.10e-03	8	165	2	PS51231
Domain	LAMININ_IVA	LAMA3 LAMA5	2.10e-03	8	165	2	PS51115
Domain	Laminin_B	LAMA3 LAMA5	2.10e-03	8	165	2	PF00052
Domain	LamB	LAMA3 LAMA5	2.10e-03	8	165	2	SM00281
Domain	Laminin_IV	LAMA3 LAMA5	2.10e-03	8	165	2	IPR000034
Domain	Cadherin_2	PCDHGC5 PCDHB13 PCDHB8 PCDH1	2.62e-03	65	165	4	PF08266
Domain	Cadherin_N	PCDHGC5 PCDHB13 PCDHB8 PCDH1	2.62e-03	65	165	4	IPR013164
Domain	Drf_GBD	DAAM2 DAAM1	2.68e-03	9	165	2	PF06371
Domain	Drf_FH3	DAAM2 DAAM1	2.68e-03	9	165	2	PF06367
Domain	FH3_dom	DAAM2 DAAM1	2.68e-03	9	165	2	IPR010472
Domain	GTPase-bd	DAAM2 DAAM1	2.68e-03	9	165	2	IPR010473
Domain	Drf_FH3	DAAM2 DAAM1	2.68e-03	9	165	2	SM01139
Domain	Drf_GBD	DAAM2 DAAM1	2.68e-03	9	165	2	SM01140
Domain	Znf_FYVE-rel	ZFYVE16 RPH3A WDFY2	3.31e-03	34	165	3	IPR017455
Domain	VDCCAlpha1	CACNA1C CACNA1S	3.33e-03	10	165	2	IPR002077
Domain	GBD/FH3_dom	DAAM2 DAAM1	4.05e-03	11	165	2	IPR014768
Domain	GBD_FH3	DAAM2 DAAM1	4.05e-03	11	165	2	PS51232
Domain	GAIN_dom_N	ADGRB3 CELSR1	4.05e-03	11	165	2	IPR032471
Domain	Laminin_G_1	CSPG4 AGRN	4.05e-03	11	165	2	PF00054
Domain	GAIN	ADGRB3 CELSR1	4.05e-03	11	165	2	PF16489
Domain	Znf_FYVE	ZFYVE16 RPH3A WDFY2	4.55e-03	38	165	3	IPR000306
Domain	Myosin_head_motor_dom	MYH2 MYH3 MYO15B	4.55e-03	38	165	3	IPR001609
Domain	MYOSIN_MOTOR	MYH2 MYH3 MYO15B	4.55e-03	38	165	3	PS51456
Domain	Myosin_head	MYH2 MYH3 MYO15B	4.55e-03	38	165	3	PF00063
Domain	MYSc	MYH2 MYH3 MYO15B	4.55e-03	38	165	3	SM00242
Domain	ZF_FYVE	ZFYVE16 RPH3A WDFY2	5.26e-03	40	165	3	PS50178
Domain	Cadherin_C	PCDHGC5 PCDHB13 PCDHB8	6.04e-03	42	165	3	IPR032455
Domain	Cadherin_C_2	PCDHGC5 PCDHB13 PCDHB8	6.04e-03	42	165	3	PF16492
Domain	FH2	DAAM2 DAAM1	7.55e-03	15	165	2	PS51444
Domain	FH2_Formin	DAAM2 DAAM1	7.55e-03	15	165	2	IPR015425
Domain	FH2	DAAM2 DAAM1	7.55e-03	15	165	2	PF02181
Domain	Myosin_N	MYH2 MYH3	7.55e-03	15	165	2	PF02736
Domain	Myosin_N	MYH2 MYH3	7.55e-03	15	165	2	IPR004009
Domain	FH2	DAAM2 DAAM1	7.55e-03	15	165	2	SM00498
Domain	PDZ	SHROOM3 ARHGEF11 TIAM1 LMO7 SNTB2	8.36e-03	141	165	5	PF00595
Domain	Laminin_N	LAMA3 LAMA5	8.58e-03	16	165	2	IPR008211
Domain	SEC7	PSD ARFGEF3	8.58e-03	16	165	2	PS50190
Domain	LamNT	LAMA3 LAMA5	8.58e-03	16	165	2	SM00136
Domain	Sec7	PSD ARFGEF3	8.58e-03	16	165	2	SM00222
Domain	LAMININ_NTER	LAMA3 LAMA5	8.58e-03	16	165	2	PS51117
Domain	Sec7_dom	PSD ARFGEF3	8.58e-03	16	165	2	IPR000904
Domain	Laminin_N	LAMA3 LAMA5	8.58e-03	16	165	2	PF00055
Domain	EGF-like_CS	LAMA3 LAMA5 HHIP CELSR1 VCAN AGRN EPHA1	8.62e-03	261	165	7	IPR013032
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SHROOM3 UVSSA MATR3 FNBP4 ADGRB3 AKNA LAMA5 CLOCK NUAK2 LMO7 SERINC1 TNKS1BP1 DAAM1 CEP126 BSN ESPL1 PLXNB1 ZNF646 NIN	1.57e-11	529	169	19	14621295
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR SPTAN1 MATR3 NUMA1 FNBP4 IRAK1 PRPF40A SETD2 NCAPG LMO7 ANLN GIGYF2 TNKS1BP1 BOD1L1 SNRNP200 THRAP3 SYMPK	1.84e-09	549	169	17	38280479
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FLNC SHROOM3 EPPK1 PPRC1 INPPL1 KAT6A MYOM3 AKNA IRAK1 LAMA5 ARHGEF11 WASHC2A C2CD2L TBC1D16 URB1 CELSR1 AATK CSPG4 TNKS1BP1 ESPL1 AGRN PCNT SYMPK	4.81e-09	1105	169	23	35748872
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR WASHC2C ZFYVE16 MATR3 NUMA1 ANKRD26 IRAK1 PSMD4 PRPF40A RBM39 USP8 SETD2 CLMN MKI67 GIGYF2 TNKS1BP1 BOD1L1 UTRN SNRNP200 ATP5F1A PCNT	6.31e-09	934	169	21	33916271
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CACNA1C MYH2 MYH3 FLNC PCDHGC5 PPRC1 SPTAN1 MATR3 NUMA1 ANKRD26 ATP10B NDUFS1 RYR2 USP8 STRN CLCN3 LMO7 CLRN3 CSPG4 BOD1L1 BSN THRAP3 ATP5F1A CCDC158 PHTF1 PCNT	8.40e-09	1442	169	26	35575683
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR WASHC2C SPTAN1 MATR3 NUMA1 FNBP4 ZC3H18 PRPF40A USP19 SETD2 LMO7 ANLN MKI67 GIGYF2 TNKS1BP1 ESPL1 SNRNP200 THRAP3 SYMPK	8.70e-09	774	169	19	15302935
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	FLNC SHROOM3 EPPK1 SPTAN1 MATR3 NUMA1 IRAK1 PRPF40A NDUFS1 RBM39 LMO7 NEXN SNRNP200 THRAP3 ATP5F1A	1.41e-08	477	169	15	31300519
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	WASHC2C LRCH2 ZFYVE16 PPRC1 WASHC2A USP19 C2CD2L ARFGEF3 TRIL USP8 GIGYF2 DAAM2 BOD1L1 PCNT	1.43e-08	407	169	14	12693553
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ADGRB3 C2CD2L URB1 AATK LMO7 GIGYF2 TNKS1BP1 SNRNP200 UNC80 PCNT NIN	1.53e-08	225	169	11	12168954
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MYH2 FLNC ZBTB2 BARD1 AGGF1 PSMD4 ZC3H18 NDUFS1 KLHL20 USP19 USP8 STRN GLDC SURF2 HLTF GIGYF2 UTRN SNRNP200 SNTB2 RAD23A NIN	2.23e-08	1005	169	21	19615732
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR FLNC EPPK1 SPTAN1 NUMA1 ZC3H18 PRPF40A NDUFS1 RBM39 URB1 MKI67 GIGYF2 TNKS1BP1 UTRN SNRNP200 PCNT SYMPK	2.37e-08	653	169	17	22586326
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR FLNC SPTAN1 MATR3 NUMA1 PSMD4 NDUFS1 LMO7 ANLN CNDP2 TNKS1BP1 UTRN PCNT	2.71e-08	360	169	13	33111431
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TPR SHROOM3 EPPK1 SPTAN1 PRPF40A RBM39 NCAPG MYO15B LMO7 ANLN HLTF TNKS1BP1 SNRNP200 THRAP3 PCNT SYMPK	2.97e-08	582	169	16	20467437
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	TPR LRCH2 SPTAN1 NUMA1 FNBP4 WASHC2A PRPF40A LMO7 ANLN MKI67 BOD1L1 UTRN SNRNP200 THRAP3 ATP5F1A	3.07e-08	506	169	15	30890647
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	SHROOM3 LRCH2 RUNDC3B SPTAN1 ANKRD26 ANKRD44 USP8 STRN LMO7 GIGYF2 NME7 UTRN SNTB2 NIN	4.47e-08	446	169	14	24255178
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SHROOM3 INPPL1 SPTAN1 MATR3 ANKRD26 PLEKHG2 STIL NUAK2 ARFGEF3 USP8 TIAM1 LMO7 ANLN CLMN GIGYF2 TNKS1BP1 BOD1L1 KIF13A UTRN	4.69e-08	861	169	19	36931259
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	FLNC NUMA1 LAMA5 PSMD4 ZC3H18 PRPF40A ARFGEF3 BOD1L1 UTRN SNRNP200 THRAP3 SNTB2	4.94e-08	313	169	12	38270169
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	TPR MATR3 NUMA1 FNBP4 ZC3H18 URB1 GIGYF2 NEXN SNRNP200 THRAP3	6.26e-08	202	169	10	24639526
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	TPR EPPK1 WASHC2C SPTAN1 NUMA1 RNF213 NCAPG LMO7 ANLN BOD1L1 SNRNP200 SYMPK	9.37e-08	332	169	12	32786267
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	EPPK1 DCAF8 LRCH2 SPTAN1 MATR3 LAMA3 STRN MYO15B GIGYF2 NME7 AGRN SNRNP200 ATP5F1A SNTB2 SYMPK RAD23A	1.06e-07	639	169	16	23443559
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLNC LRCH2 SPTAN1 MATR3 ARHGEF11 PRPF40A RPH3A NDUFS1 RBM39 PNMA8B NUAK2 STRN LMO7 CLMN CRACDL VCAN TNKS1BP1 BSN PCDH1 UTRN SNRNP200 THRAP3 ATP5F1A MAPK8IP2	1.28e-07	1431	169	24	37142655
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TPR WASHC2C PPRC1 MATR3 WASHC2A URB1 TEX264 ANLN CLMN VCAN BOD1L1 KIF13A ESPL1 NEXN UTRN AGRN CNOT2 ATP5F1A PLXNB1 PCNT	3.60e-07	1084	169	20	11544199
Pubmed	Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles.	NUMA1 PRPF40A SETD2 SYMPK	7.04e-07	15	169	4	11092755
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SHROOM3 ZFYVE16 INPPL1 SPTAN1 IRAK1 USP8 LMO7 ANLN CLMN GIGYF2 TNKS1BP1 DAAM1 PCDH1 UTRN	7.78e-07	565	169	14	25468996
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	TPR FLNC SPTAN1 MATR3 NUMA1 ADGRB3 PSMD4 PRPF40A RBM39 NCAPG BOD1L1 PIPSL UTRN SNRNP200 THRAP3 ATP5F1A PCNT	9.23e-07	847	169	17	35235311
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TPR DCAF8 WASHC2C RETREG2 MATR3 NUMA1 AGGF1 WASHC2A RBM39 STRN URB1 ANLN MKI67 MCRS1 TNKS1BP1 ESPL1 NEXN SNRNP200 THRAP3 CNOT2	9.63e-07	1155	169	20	20360068
Pubmed	Heart neurons use clock genes to control myocyte proliferation.	CACNA1C CLOCK RYR2 ANLN MKI67	9.81e-07	37	169	5	34851661
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	NUMA1 ANKRD26 BARD1 AGGF1 PSMD4 PRPF40A RBM39 ANKRD44 STRN NCAPG MKI67 MCRS1 SNRNP200 THRAP3 PCNT	1.10e-06	670	169	15	22990118
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1C SPTAN1 ADGRB3 PEX5L C2CD2L RAB3IP GIGYF2 TMEM163 TNKS1BP1 BSN SNTB2	1.18e-06	347	169	11	17114649
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR SHROOM3 LRCH2 SPTAN1 MATR3 NUMA1 ADGRB3 ARHGEF11 PEX5L RPH3A STRN RAB3IP GIGYF2 BSN AGRN THRAP3 MAPK8IP2 PCNT	1.20e-06	963	169	18	28671696
Pubmed	Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease.	CACNA1S NUMA1 STRN TNKS1BP1	1.22e-06	17	169	4	22153077
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TPR WASHC2C NUMA1 IFIT3 LMO7 ANLN MKI67 MCRS1 TNKS1BP1 KIF13A THRAP3 SNTB2 EPHA1	1.23e-06	503	169	13	16964243
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCAF8 PPRC1 SPTAN1 ADGRB3 PSMD4 RPH3A USP8 UBA7 FBH1 TIAM1 LMO7 ZNF197 DAAM2 MCRS1 MIGA1 UTRN SNRNP200 CNOT2 ATP5F1A MAPK8IP2 PCNT	1.27e-06	1285	169	21	35914814
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	EPPK1 SPTAN1 NUMA1 LAMA5 RBM39 VCAN AGRN SNRNP200 ATP5F1A	1.38e-06	219	169	9	31353912
Pubmed	140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.	TPR SPTAN1 MATR3 RPH3A ARFGEF3 STRN CRACDL NIN	1.44e-06	163	169	8	16512683
Pubmed	Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.	TPR NUMA1 ANKRD26 RNF213 SETD2 NFIL3 CCDC158	1.69e-06	116	169	7	21282530
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	TPR SPTAN1 ANLN MKI67 TNKS1BP1 UTRN PCNT	1.89e-06	118	169	7	30979931
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MYH2 DCAF8 SPTAN1 NUMA1 IRAK1 RNF213 PSMD4 IFIT3 NDUFS1 RBM39 GFM2 ARFGEF3 URB1 NCAPG LMO7 MKI67 HLTF TNKS1BP1 NEXN SNRNP200 THRAP3 ATP5F1A	2.09e-06	1440	169	22	30833792
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	SPTAN1 MATR3 PEX5L RBM39 C2CD2L TIAM1 CLMN BSN THRAP3	2.14e-06	231	169	9	16452087
Pubmed	Type 3 and type 1 ryanodine receptors are localized in triads of the same mammalian skeletal muscle fibers.	CACNA1S MYH2 MYH3	2.23e-06	6	169	3	10444070
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	TPR MATR3 NUMA1 PRPF40A RBM39 GIGYF2 KIF13A SNRNP200 THRAP3	2.38e-06	234	169	9	36243803
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TPR WASHC2C RETREG2 SPTAN1 ADGRB3 PSMD4 WASHC2A RPH3A NDUFS1 RBM39 RYR2 C2CD2L ARFGEF3 STRN CNDP2 DAAM1 BSN THRAP3 CNOT2	3.15e-06	1139	169	19	36417873
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SHROOM3 DCAF8 SPTAN1 FNBP4 ANKRD26 WASHC2A PRPF40A NDUFS1 URB1 NCAPG TIAM1 TEX264 CLMN CNDP2 DAAM1 NME7 ESPL1 SNRNP200 SNTB2 PCNT RAD23A NIN	3.51e-06	1487	169	22	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNA1C ABCC4 SHROOM3 DCAF8 UVSSA KAT6A FNBP4 BARD1 LAMA3 RNF213 RBM39 ARFGEF3 ANKRD44 CLMN RAB3IP CNDP2 BOD1L1 DAAM1 PCDH1 UTRN THRAP3 PCNT	3.58e-06	1489	169	22	28611215
Pubmed	Comprehensive Characterization of Tissues Derived from Animals at Different Regenerative Stages: A Comparative Analysis between Fetal and Adult Mouse Skin.	VCAN MKI67 AGRN	3.89e-06	7	169	3	37174615
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	TPR WASHC2C MATR3 NUMA1 FNBP4 LAMA5 ZC3H18 PRPF40A RBM39 URB1 LMO7 MKI67 GIGYF2 SNRNP200 THRAP3 SYMPK	4.24e-06	847	169	16	35850772
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	TPR FLNC MATR3 NUMA1 PSMD4 PRPF40A SETD2 MKI67 TNKS1BP1 BOD1L1 THRAP3	4.52e-06	399	169	11	35987950
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SHROOM3 WASHC2C LRCH2 ANKRD26 IRAK1 PLEKHG2 STIL ARHGEF11 WASHC2A RBM39 STRN GIGYF2 NME7 AGRN PCNT NIN	4.63e-06	853	169	16	28718761
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	TPR SPTAN1 MATR3 NUMA1 PSMD4 ZC3H18 ARHGEF11 PRPF40A ANLN MKI67 TNKS1BP1 SNRNP200 THRAP3 SNTB2	4.72e-06	660	169	14	32780723
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	WASHC2C INPPL1 ANKRD26 ZC3H18 WASHC2A ARFGEF3 SETD2 STRN LMO7 TNKS1BP1 BSN PCNT NIN	6.71e-06	588	169	13	38580884
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	SPTAN1 MATR3 NUMA1 PRPF40A RBM39 FBH1 LMO7 HLTF SNRNP200 SYMPK	7.07e-06	340	169	10	24332808
Pubmed	Epidermal development requires ninein for spindle orientation and cortical microtubule organization.	NUMA1 MKI67 PCNT NIN	7.40e-06	26	169	4	30923192
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SPTAN1 MATR3 PRPF40A RBM39 NFIL3 MKI67 BOD1L1 SNRNP200 THRAP3	8.05e-06	272	169	9	31010829
Pubmed	Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a novel tankyrase partner.	CACNA1S NUMA1 TNKS1BP1	9.27e-06	9	169	3	12080061
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	EPPK1 NUMA1 NCAPG MKI67 MCRS1 SNRNP200 THRAP3 PCNT	9.39e-06	210	169	8	16565220
Pubmed	Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice.	PCDHB13 PCDHB8 SETD2 CDH8	1.01e-05	28	169	4	33523829
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TPR FLNC SPTAN1 MATR3 NUMA1 PSMD4 NDUFS1 RBM39 URB1 NCAPG ANLN MKI67 HLTF NME7 NEXN UTRN AGRN SNRNP200 THRAP3 ATP5F1A	1.02e-05	1353	169	20	29467282
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TPR MATR3 NUMA1 PSMD4 ZC3H18 MKI67 BOD1L1 SNRNP200 THRAP3	1.11e-05	283	169	9	30585729
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	FLNC WASHC2C WASHC2A STRN GIGYF2 UTRN SNRNP200 THRAP3	1.11e-05	215	169	8	35973513
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TPR FLNC EPPK1 MATR3 NUMA1 IRAK1 PRPF40A RBM39 URB1 LMO7 MKI67 GIGYF2 UTRN SNRNP200 THRAP3 ATP5F1A PCNT	1.14e-05	1024	169	17	24711643
Pubmed	Photocaged Cell-Permeable Ubiquitin Probe for Temporal Profiling of Deubiquitinating Enzymes.	EPPK1 NUMA1 USP19 TXNRD1 USP8	1.54e-05	64	169	5	33141564
Pubmed	HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.	SPTAN1 LMO7 ANLN HLTF	1.74e-05	32	169	4	27114546
Pubmed	Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1.	MYH3 VCAN MKI67	1.81e-05	11	169	3	37254794
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	TPR MYH2 MYH3 EPPK1 SPTAN1 LAMA5 PSMD4 NDUFS1 NCAPG LMO7 TNKS1BP1 DAAM1 ATP5F1A	1.84e-05	647	169	13	26618866
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR MATR3 NUMA1 FNBP4 ZC3H18 PRPF40A RBM39 SETD2 ANLN MKI67 GIGYF2 BOD1L1 SNRNP200 THRAP3 ATP5F1A SYMPK	1.85e-05	954	169	16	36373674
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MATR3 NUMA1 FNBP4 BARD1 ZC3H18 CLOCK PRPF40A RBM39 SETD2 URB1 LMO7 NFIL3 MKI67 HLTF MCRS1 SNRNP200 THRAP3 ATP5F1A SYMPK	1.90e-05	1294	169	19	30804502
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	TPR FLNC EPPK1 DCAF8 RNF213 STRN GLDC TNKS1BP1 SNRNP200	1.95e-05	304	169	9	32235678
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	TPR EPPK1 SPTAN1 MATR3 NUMA1 BARD1 PRPF40A NDUFS1 LMO7 MKI67 SNRNP200 THRAP3 ATP5F1A	1.99e-05	652	169	13	31180492
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FLNC LRCH2 SPTAN1 MATR3 FNBP4 ZC3H18 PRPF40A NDUFS1 RBM39 SETD2 VCAN TNKS1BP1 AGRN SNRNP200 THRAP3 PLXNB1 SYMPK	2.30e-05	1082	169	17	38697112
Pubmed	Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse.	VCAN CSPG4	2.35e-05	2	169	2	17900358
Pubmed	Temporal expression of calcium channel subunits in satellite cells and bone marrow mesenchymal cells.	CACNA1C CACNA1S	2.35e-05	2	169	2	25277766
Pubmed	Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.	VCAN CSPG4	2.35e-05	2	169	2	15609081
Pubmed	A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice.	CACNA1C CACNA1S	2.35e-05	2	169	2	1281468
Pubmed	Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp).	WASHC2C WASHC2A	2.35e-05	2	169	2	20827171
Pubmed	FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans.	WASHC2C WASHC2A	2.35e-05	2	169	2	36717248
Pubmed	Identification of chick and mouse Daam1 and Daam2 genes and their expression patterns in the central nervous system.	DAAM2 DAAM1	2.35e-05	2	169	2	15464228
Pubmed	Lack of centrioles and primary cilia in STIL(-/-) mouse embryos.	STIL PCNT	2.35e-05	2	169	2	25486474
Pubmed	Kendrin is a novel substrate for separase involved in the licensing of centriole duplication.	ESPL1 PCNT	2.35e-05	2	169	2	22542101
Pubmed	Molecular mechanism for divergent regulation of Cav1.2 Ca2+ channels by calmodulin and Ca2+-binding protein-1.	CABP1 CACNA1C	2.35e-05	2	169	2	15980432
Pubmed	Intestinal Paneth cell differentiation relies on asymmetric regulation of Wnt signaling by Daam1/2.	DAAM2 DAAM1	2.35e-05	2	169	2	38000028
Pubmed	Identification of a novel Rev-interacting cellular protein.	WASHC2C WASHC2A	2.35e-05	2	169	2	15847701
Pubmed	In situ-RT-PCR and immunohistochemistry for the localisation of the mRNA of the alpha 3 chain of laminin and laminin-5 during human organogenesis.	LAMA3 LAMA5	2.35e-05	2	169	2	12382139
Pubmed	Biological function of laminin-5 and pathogenic impact of its deficiency.	LAMA3 LAMA5	2.35e-05	2	169	2	17000025
Pubmed	Structural basis for the differential effects of CaBP1 and calmodulin on Ca(V)1.2 calcium-dependent inactivation.	CABP1 CACNA1C	2.35e-05	2	169	2	21134641
Pubmed	Skeletal and cardiac ryanodine receptors bind to the Ca(2+)-sensor region of dihydropyridine receptor alpha(1C) subunit.	CACNA1C RYR2	2.35e-05	2	169	2	11576544
Pubmed	Endogenous cardiac Ca2+ channels do not overcome the E-C coupling defect in immortalized dysgenic muscle cells: evidence for a missing link.	CACNA1C CACNA1S	2.35e-05	2	169	2	7635187
Pubmed	ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.	ANLN MKI67	2.35e-05	2	169	2	27863473
Pubmed	DNA-repair protein hHR23a alters its protein structure upon binding proteasomal subunit S5a.	PSMD4 RAD23A	2.35e-05	2	169	2	14557549
Pubmed	Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines.	VCAN CSPG4	2.35e-05	2	169	2	16625365
Pubmed	Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice.	TMEM163 AGRN	2.35e-05	2	169	2	22082664
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	LAMA3 LAMA5 AGRN	2.40e-05	12	169	3	16750824
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	SPTAN1 IRAK1 PSMD4 WASHC2A NDUFS1 GIGYF2 ESPL1 SYMPK	2.61e-05	242	169	8	34011540
Pubmed	Fukutin-related protein alters the deposition of laminin in the eye and brain.	LAMA3 LAMA5 MKI67	3.11e-05	13	169	3	21900571
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	TPR MYH2 SPTAN1 LAMA5 RNF213 SETD2 TIAM1 MKI67	3.29e-05	250	169	8	33536335
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	SHROOM3 LRCH2 ZFYVE16 STRN UTRN SNTB2	3.50e-05	125	169	6	29467281
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLNC ZFYVE16 FNBP4 LAMA5 PRPF40A RYR2 STRN CSPG4 DAAM1 KIF13A PCDH1 UTRN	3.52e-05	591	169	12	15231748
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	DCAF8 LRCH2 INPPL1 KAT6A AGGF1 PSMD4 NDUFS1 STRN C17orf75 CLMN SYMPK ZNF646 RAD23A	3.53e-05	689	169	13	36543142
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGC5 PCDHB13 PCDHB8 CELSR1 PCDH1	3.80e-05	77	169	5	10835267
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TPR MATR3 NUMA1 RNF213 ZC3H18 PRPF40A TXNRD1 SETD2 NCAPG MKI67 HLTF CNDP2 BOD1L1 THRAP3 SYMPK RAD23A	3.84e-05	1014	169	16	32416067
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	TPR EPPK1 SPTAN1 LMO7 ANLN GIGYF2 TNKS1BP1 SNRNP200	3.89e-05	256	169	8	33397691
Interaction	WDR76 interactions	EPPK1 DCAF8 SPTAN1 NUMA1 LAMA5 RBM39 LRFN4 VCAN MKI67 HLTF PIPSL UTRN AGRN SNRNP200 ATP5F1A	7.40e-07	383	167	15	int:WDR76
Interaction	EPB41L2 interactions	TPR ZBTB2 DCAF8 SPTAN1 NUMA1 FNBP4 ZC3H18 PRPF40A NUAK2 ANLN CNDP2 ATP5F1A	7.73e-06	299	167	12	int:EPB41L2
Interaction	SLC35G1 interactions	AGGF1 RNF213 ANKRD44 SETD2 TNKS1BP1	8.43e-06	34	167	5	int:SLC35G1
Interaction	USP7 interactions	TPR CACNA1C MYH3 LRCH2 SPTAN1 UVSSA MATR3 NUMA1 MYOM3 IRAK1 PSMD4 STIL PRPF40A RBM39 USP19 NUAK2 TRIL C9orf152 HHIP ANLN HLTF GIGYF2 BSN KIF13A UTRN SNRNP200 THRAP3	1.06e-05	1313	167	27	int:USP7
Interaction	LGR4 interactions	TPR MATR3 NUMA1 FNBP4 ZC3H18 URB1 GIGYF2 DAAM2 NEXN SNRNP200 THRAP3	1.23e-05	262	167	11	int:LGR4
Interaction	YWHAH interactions	SHROOM3 EPPK1 LRCH2 INPPL1 SPTAN1 MATR3 ANKRD26 PLEKHG2 STIL RPH3A TESPA1 NUAK2 ARFGEF3 USP8 TIAM1 LMO7 ANLN CLMN GIGYF2 TNKS1BP1 BOD1L1 UTRN PCNT NIN	1.38e-05	1102	167	24	int:YWHAH
Interaction	SNRPC interactions	ZBTB2 PPRC1 MATR3 BARD1 AGGF1 ZC3H18 PRPF40A IFIT3 RBM39 SETD2 GIGYF2 SNRNP200 THRAP3 NIN	1.88e-05	440	167	14	int:SNRPC
Interaction	ZBTB44 interactions	AGGF1 KLHL20 SETD2 TIAM1 FAM124A RAD23A	1.94e-05	67	167	6	int:ZBTB44
Interaction	ADRA1D interactions	FLNC ANLN UTRN SNTB2	2.44e-05	21	167	4	int:ADRA1D
Interaction	SNRNP200 interactions	ZBTB2 MATR3 KAT6A BARD1 IRAK1 ZC3H18 RBM39 USP19 ANLN MKI67 BOD1L1 AGRN SNRNP200 THRAP3	3.06e-05	460	167	14	int:SNRNP200
Interaction	HCN1 interactions	SHROOM3 EPPK1 PEX5L RPH3A RAB3IP BSN MAPK8IP2	3.27e-05	108	167	7	int:HCN1
Interaction	CC2D1A interactions	DCAF8 ZFYVE16 STIL KLHL20 AATK PIPSL THRAP3 NIN	4.01e-05	152	167	8	int:CC2D1A
Interaction	FMR1 interactions	ZBTB2 LRCH2 MATR3 KAT6A NUMA1 RBM39 RNF214 AATK GLDC ANLN MKI67 GIGYF2 BSN THRAP3 PCNT	4.16e-05	536	167	15	int:FMR1
Interaction	MEN1 interactions	WASHC2C MATR3 NUMA1 FNBP4 LAMA5 RNF213 ZC3H18 PRPF40A URB1 LMO7 ANLN MKI67 GIGYF2 MCRS1 TNKS1BP1 BOD1L1 SNRNP200 THRAP3 CNOT2 SYMPK RAD23A NIN	4.30e-05	1029	167	22	int:MEN1
Interaction	ZCCHC8 interactions	INPPL1 MATR3 ZC3H18 PRPF40A GLDC MKI67 GIGYF2 AGRN	4.40e-05	154	167	8	int:ZCCHC8
Interaction	PNN interactions	ZBTB2 NUMA1 BARD1 ZC3H18 PRPF40A RBM39 KLHL20 GLDC ANLN MKI67 THRAP3	4.54e-05	302	167	11	int:PNN
Interaction	VCP interactions	CACNA1C EPPK1 SPTAN1 MATR3 NUMA1 BARD1 PSMD4 NDUFS1 RBM39 TXNRD1 NCAPG GLDC ANLN MKI67 FBXO43 CNDP2 GIGYF2 TNKS1BP1 ESPL1 AGRN THRAP3 CNOT2 ATP5F1A SNTB2 MAPK8IP2 SYMPK RAD23A	5.07e-05	1435	167	27	int:VCP
Interaction	TMOD1 interactions	SPTAN1 ARHGEF11 STRN LMO7 ANLN NEXN PCNT NIN	6.03e-05	161	167	8	int:TMOD1
Interaction	NAA40 interactions	TPR WASHC2C ZFYVE16 MATR3 NUMA1 ANKRD26 IRAK1 PSMD4 PRPF40A RBM39 USP8 SETD2 CLMN MKI67 GIGYF2 TNKS1BP1 BOD1L1 UTRN SNRNP200 ATP5F1A PCNT	6.13e-05	978	167	21	int:NAA40
Interaction	ACTC1 interactions	TPR LRCH2 SPTAN1 NUMA1 FNBP4 WASHC2A PRPF40A AATK LMO7 ANLN MKI67 BOD1L1 NEXN UTRN SNRNP200 THRAP3 ATP5F1A	6.69e-05	694	167	17	int:ACTC1
Interaction	ARRDC2 interactions	FLNC PSMD4 BOD1L1 PIPSL SNRNP200	8.38e-05	54	167	5	int:ARRDC2
Interaction	CFTR interactions	TPR MYH2 MYH3 FLNC ABCC4 SHROOM3 EPPK1 SPTAN1 PCDHB8 LAMA3 LAMA5 MAGEC3 PSMD4 NDUFS1 RBM39 USP19 RYR2 LRFN4 NCAPG CLCN3 TIAM1 LMO7 ANLN NFIL3 TNKS1BP1 DAAM1 ATP5F1A	8.55e-05	1480	167	27	int:CFTR
Interaction	DYNLL1 interactions	TPR SHROOM3 ZBTB2 NUMA1 AGGF1 ZC3H18 RBM39 RNF214 STRN LRFN4 ANLN MIGA1 ATP5F1A PCNT	9.27e-05	510	167	14	int:DYNLL1
Interaction	CTNNB1 interactions	SHROOM3 ZBTB2 ABCA4 SPTAN1 MATR3 NUMA1 ANKRD26 PSMD4 PEX5L RBM39 USP8 LMO7 GLDC ANLN CLMN MKI67 UTRN CDH8 THRAP3 CNOT2 ATP5F1A	9.52e-05	1009	167	21	int:CTNNB1
Interaction	RPA4 interactions	SPTAN1 MATR3 NUMA1 PSMD4 ZC3H18 WASHC2A PRPF40A ARFGEF3 SETD2 STRN MKI67 THRAP3 CNOT2	1.05e-04	452	167	13	int:RPA4
Interaction	OTUD7A interactions	SPTAN1 ADGRB3 ARFGEF3 STRN TNKS1BP1	1.18e-04	58	167	5	int:OTUD7A
Interaction	H1-10 interactions	ZBTB2 UVSSA KAT6A NUMA1 ZC3H18 PRPF40A RBM39 URB1 ANLN EPHA1	1.19e-04	280	167	10	int:H1-10
Interaction	POLD1 interactions	TPR MATR3 KAT6A PRPF40A NCAPG MKI67 CEP126 CNOT2 MAPK8IP2 PCNT SYMPK	1.21e-04	337	167	11	int:POLD1
Interaction	GOLGA1 interactions	WASHC2C ANKRD26 WASHC2A ARFGEF3 STRN CLMN TNKS1BP1 PCNT	1.47e-04	183	167	8	int:GOLGA1
Interaction	MZT1 interactions	LYSMD2 ZC3H18 BOD1L1 NME7 PCNT	1.50e-04	61	167	5	int:MZT1
Interaction	SIRT7 interactions	TPR FLNC EPPK1 SPTAN1 NUMA1 ZC3H18 PRPF40A NDUFS1 RBM39 URB1 MKI67 GIGYF2 TNKS1BP1 UTRN SNRNP200 PCNT SYMPK	1.55e-04	744	167	17	int:SIRT7
Interaction	ANKFY1 interactions	ZFYVE16 KAT6A WASHC2A ARFGEF3 ANKRD44 AATK TNKS1BP1 CCDC158 PCNT	1.60e-04	236	167	9	int:ANKFY1
Interaction	FBXW11 interactions	FLNC DCAF8 LRCH2 MATR3 IRAK1 ZC3H18 STIL NUAK2 AATK TIAM1 HLTF THRAP3 MAPK8IP2	1.64e-04	473	167	13	int:FBXW11
Interaction	PRC1 interactions	TPR FLNC EPPK1 SPTAN1 MATR3 NUMA1 ZC3H18 PRPF40A NDUFS1 URB1 NCAPG LMO7 ANLN CRACDL MKI67 HLTF KIF13A SNRNP200 THRAP3 ATP5F1A	1.67e-04	973	167	20	int:PRC1
Interaction	KIF20A interactions	FLNC SHROOM3 EPPK1 SPTAN1 MATR3 NUMA1 ZC3H18 PRPF40A URB1 LMO7 ANLN MKI67 HLTF GIGYF2 PIP5K1B BOD1L1 KIF13A UTRN SNRNP200 THRAP3 ATP5F1A	1.70e-04	1052	167	21	int:KIF20A
Interaction	CWC22 interactions	PSMD4 ZC3H18 PRPF40A RBM39 ANLN MKI67 SNRNP200	1.76e-04	141	167	7	int:CWC22
Interaction	CNOT10 interactions	STIL KLHL20 RNF214 AATK MKI67 TNKS1BP1 CNOT2	1.76e-04	141	167	7	int:CNOT10
Interaction	SMARCA5 interactions	TPR ZBTB2 NUMA1 ZC3H18 PRPF40A RBM39 KLHL20 NCAPG AATK ANLN PIPSL SYMPK	1.84e-04	415	167	12	int:SMARCA5
Interaction	CHD3 interactions	TPR ZBTB2 RETREG2 MATR3 KAT6A NUMA1 FNBP4 BARD1 ZC3H18 PRPF40A RBM39 MKI67 SNRNP200 THRAP3 ATP5F1A PCNT SYMPK	1.90e-04	757	167	17	int:CHD3
Interaction	PPHLN1 interactions	MATR3 ZC3H18 RBM39 SETD2 ANLN MKI67 THRAP3	2.19e-04	146	167	7	int:PPHLN1
Interaction	TOP1 interactions	TPR ZBTB2 MATR3 KAT6A BARD1 ZC3H18 PRPF40A RBM39 SETD2 TIAM1 GLDC ANLN MKI67 SNRNP200 THRAP3 SYMPK	2.27e-04	696	167	16	int:TOP1
Interaction	SAP18 interactions	TPR ZBTB2 SPTAN1 MATR3 ZC3H18 PRPF40A RBM39 SETD2 ANLN THRAP3	2.38e-04	305	167	10	int:SAP18
Interaction	SNTA1 interactions	ABCC4 ADGRB3 RYR2 TIAM1 UTRN SNTB2	2.42e-04	105	167	6	int:SNTA1
Interaction	ISG15 interactions	EPPK1 SPTAN1 MATR3 RNF213 PSMD4 IFIT3 TXNRD1 UBA7 LMO7 SNRNP200 THRAP3 ATP5F1A RAD23A	2.50e-04	494	167	13	int:ISG15
Interaction	ANK3 interactions	FLNC SPTAN1 TIAM1 TNKS1BP1 NEXN UTRN AGRN MAPK8IP2	2.79e-04	201	167	8	int:ANK3
Interaction	DDX39B interactions	SHROOM3 ZBTB2 SPTAN1 MATR3 BARD1 PRPF40A NDUFS1 RBM39 LMO7 GLDC ANLN SNRNP200 THRAP3 ATP5F1A	2.92e-04	570	167	14	int:DDX39B
Cytoband	3p21.31	USP19 SETD2 TEX264 BSN PLXNB1	3.62e-05	100	169	5	3p21.31
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	USP19 SETD2 UBA7 TEX264 ZNF197 BSN PLXNB1	1.82e-04	316	169	7	chr3p21
GeneFamily	WASH complex	WASHC2C WASHC2A	5.12e-04	6	107	2	1331
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	CSPG4 AGRN	7.15e-04	7	107	2	570
GeneFamily	Synaptotagmin like tandem C2 proteins	RPH3A TC2N	1.51e-03	10	107	2	822
GeneFamily	PDZ domain containing	SHROOM3 ARHGEF11 TIAM1 LMO7 SNTB2	2.10e-03	152	107	5	1220
GeneFamily	Laminin subunits	LAMA3 LAMA5	2.20e-03	12	107	2	626
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CACNA1C PSD RETREG2 RUNDC3B MUC19 LAMA3 LAMA5 LYSMD2 PEX5L RYR2 PNMA8B ARFGEF3 ANKRD44 AATK SERINC1 VCAN TMEM163 BOD1L1 PNCK DAAM1 CEP126 BSN KIF13A PCDH1 CDH8 MAPK8IP2	1.15e-08	1106	169	26	M39071
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	CACNA1C BNC2 PSD RUNDC3B ADGRB3 MUC19 PEX5L RYR2 PNMA8B ARFGEF3 ANKRD44 URB1 AATK NFIL3 PNCK DAAM1 BSN CDH8	7.38e-07	703	169	18	M39070
Coexpression	HALLMARK_MITOTIC_SPINDLE	SPTAN1 NUMA1 PLEKHG2 ARHGEF11 TIAM1 ANLN ESPL1 PCNT NIN	6.13e-06	199	169	9	M5893
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HSERT	CACNA1C PSD RUNDC3B PNMA8B ARFGEF3 ANKRD44 AATK SERINC1 TPH2 PNCK CEP126 CDH8 MAPK8IP2	7.70e-06	450	169	13	M39072
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TPR SPTAN1 MATR3 KAT6A NUMA1 FNBP4 AKNA AGGF1 LYSMD2 RNF213 PRPF40A RBM39 TESPA1 ANKRD44 SETD2 TC2N SERINC1 SLA2 BOD1L1 UTRN SNRNP200 THRAP3 CNOT2 SNTB2 NIN	1.12e-05	1492	169	25	M40023
Coexpression	FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON	CACNA1C LAMA5 RNF213 RYR2 ARFGEF3 LMO7 PNCK NIN	1.29e-05	166	169	8	M39026
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	EPPK1 ARFGEF3 TRIL C9orf152 TC2N CRACDL TNKS1BP1 DAAM1 PCDH1 PLXNB1 EPHA1 SYMPK	4.23e-05	455	169	12	M17299
Coexpression	GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN	NDUFS1 RYR2 URB1 PIP5K1B TMEM163 NEXN ATP5F1A PLXNB1	4.88e-05	200	169	8	M8465
Coexpression	HALLMARK_APICAL_JUNCTION	FLNC INPPL1 LAMA3 VCAN NEXN PCDH1 CDH8 SYMPK	4.88e-05	200	169	8	M5915
Coexpression	GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN	INPPL1 AKNA WDFY2 KLHL20 TIAM1 TMEM163 ATP5F1A SNTB2	4.88e-05	200	169	8	M9050
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	EPPK1 MROH2A STIL CELSR1 NCAPG LMO7 ANLN NEXN	4.88e-05	200	169	8	M9122
Coexpression	GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP	BRME1 KCNK12 GFM2 CELSR1 CLRN3 SURF2 KCNJ9 TPH2	4.88e-05	200	169	8	M4335
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL	PSD LYSMD2 PEX5L ARFGEF3 CEP126 UNC80 MAPK8IP2	6.83e-05	155	169	7	M45695
Coexpression	AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2	SHROOM3 LAMA5 NUAK2 CLMN VCAN RAB3IP TNKS1BP1 PLXNB1	9.22e-05	219	169	8	M39111
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 TBC1D16 ARFGEF3 HHIP CELSR1 TC2N LMO7 TMEM163	2.33e-09	184	169	10	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZFYVE16 CLOCK NDUFS1 ARFGEF3 USP8 STRN ZBED6 GIGYF2 MIGA1 UTRN	3.69e-09	193	169	10	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 ARFGEF3 HHIP CELSR1 TC2N LMO7 TMEM163	4.11e-08	186	169	9	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 ARFGEF3 HHIP CELSR1 TC2N LMO7 TMEM163	4.50e-08	188	169	9	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ATP10B PEX5L ARFGEF3 HHIP STRN AATK ANLN FAM124A MIGA1	5.39e-08	192	169	9	3ce5dbde41aeb73d49f2c7991d34682f0827fa5a
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LAMA3 STIL CELSR1 NCAPG TC2N ANLN MKI67 FBXO43 ESPL1	5.89e-08	194	169	9	c197e4acbff42a9f0410b6801c2bfcf6160aefc1
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 ARFGEF3 HHIP TC2N LMO7 TMEM163	4.34e-07	179	169	8	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 ARFGEF3 HHIP TC2N LMO7 TMEM163	4.72e-07	181	169	8	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	COVID-19_Mild-NK_activated\|COVID-19_Mild / Disease condition and Cell class	WASHC2C RETREG2 MATR3 RNF213 WASHC2A IFIT3 FBH1 ATP5F1A	5.13e-07	183	169	8	22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 ARFGEF3 HHIP TC2N LMO7 TMEM163	5.13e-07	183	169	8	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 LAMA5 CNTN6 CELSR1 LMO7 CRACDL PIP5K1B	5.35e-07	184	169	8	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	PBMC-Mild-cDC_9\|Mild / Compartment, Disease Groups and Clusters	MATR3 RNF213 SNX21 IFIT3 NDUFS1 NCAPG ZBED6 MKI67	5.35e-07	184	169	8	2e0c9a2c40c892a2d435eafb31f1f838de9baf15
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 LAMA3 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	5.57e-07	185	169	8	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 LAMA3 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	6.04e-07	187	169	8	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ARFGEF3 CELSR1 TC2N LMO7 GLDC MKI67 TMEM163 ESPL1	6.55e-07	189	169	8	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LAMA3 ATP10B STIL NCAPG TC2N ANLN MKI67 ESPL1	7.09e-07	191	169	8	39220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANO4 ZFYVE16 PEX5L ARFGEF3 HHIP AATK ANLN CLMN	7.98e-07	194	169	8	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	BNC2 ADGRB3 TXNRD1 ANKRD44 TC2N TIAM1 VCAN DAAM1	8.62e-07	196	169	8	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA4 LAMA3 CNTN6 CELSR1 LMO7 UTRN PLXNB1 CCDC158	9.30e-07	198	169	8	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BNC2 AKNA RNF213 RBM39 ANKRD44 TC2N UTRN SNRNP200	9.66e-07	199	169	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-I_(AT1)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	LAMA3 LAMA5 CNTN6 TRIL AATK LMO7 NEXN AGRN	9.66e-07	199	169	8	5a002d49a8b84c158f7b4d7a3e78e6a937757bb7
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 ARFGEF3 STRN CELSR1 LMO7 CLMN CRACDL TRPV4	1.00e-06	200	169	8	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR RNF213 IFIT3 RBM39 ANKRD44 SETD2 BOD1L1 UTRN	1.00e-06	200	169	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PEX5L ARFGEF3 HHIP AATK ANLN CLMN DAAM2 FAM124A	1.00e-06	200	169	8	0bfd41c12887479ceb62c3db0a3c3ba5007eb62b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PEX5L ARFGEF3 HHIP AATK ANLN CLMN DAAM2 FAM124A	1.00e-06	200	169	8	159377d904394d91e09913131e9a93e08189955a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANO4 PEX5L ARFGEF3 HHIP ANLN CLMN DAAM2 FAM124A	1.00e-06	200	169	8	829978708463a7459fe1041bd90196775bc4b531
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LAMA3 ARFGEF3 C9orf152 TC2N CLMN PIP5K1B TMEM163	2.17e-06	155	169	7	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MATR3 ANKRD26 TESPA1 TIAM1 PNCK ATP5F1A EPHA1	2.57e-06	159	169	7	b9d34b9ed8db798f5ea93c44b469cae499403cb8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	3.29e-06	165	169	7	eec2d327c94832d1390314c93ef6a2be4648478b
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	NUMA1 USP19 SETD2 GIGYF2 TEX44 THRAP3 PLXNB1	3.42e-06	166	169	7	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZBTB2 STIL NEK3 CELSR1 NCAPG MKI67 ESPL1	3.56e-06	167	169	7	754e6412d3b9cc0b126e59593df2f5956b4712ef
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	3.56e-06	167	169	7	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 LAMA3 STIL NCAPG ANLN MKI67 FBXO43	3.85e-06	169	169	7	0bc8ef341ce307b19018d4ac8de0a4d04254209d
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STIL ENO4 NCAPG ANLN MKI67 FBXO43 ESPL1	4.67e-06	174	169	7	94575a605c725de83f66a6cf7df9d7bb360ffc56
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STIL ENO4 NCAPG ANLN MKI67 FBXO43 ESPL1	4.67e-06	174	169	7	40c81ab36d7931e271e20d7d56fed32463c75f41
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C ABCC4 PEX5L TXNRD1 LRFN4 DAAM1 BSN	4.67e-06	174	169	7	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	4.67e-06	174	169	7	dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STIL ENO4 NCAPG ANLN MKI67 FBXO43 ESPL1	4.67e-06	174	169	7	b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	4.84e-06	175	169	7	876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CABP1 BARD1 NCAPG ANLN CSPG4 MKI67 ESPL1	5.03e-06	176	169	7	45c6983ab671b0f306e7390320bd84f848e474cc
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 CNTN6 CELSR1 LMO7 DAAM2 UTRN	5.22e-06	177	169	7	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BARD1 STIL NEK3 NCAPG ANLN MKI67 ESPL1	5.62e-06	179	169	7	54191c00b29f53b520cd3243b5791daa4a2c72d7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 LAMA3 STIL NCAPG ANLN MKI67 ESPL1	5.62e-06	179	169	7	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	CACNA1C EPPK1 LAMA3 CLMN CSPG4 PIP5K1B DAAM2	5.62e-06	179	169	7	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	AT1_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	LAMA3 LAMA5 CNTN6 TRIL LMO7 AGRN PLXNB1	5.62e-06	179	169	7	1603117b52623663458a977c94bf7f9f6c1114b8
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BARD1 STIL NEK3 NCAPG ANLN MKI67 ESPL1	5.83e-06	180	169	7	5e1680088065be14447d5d5465f91f7edd071a1e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	5.83e-06	180	169	7	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C LRCH2 RYR2 CLMN CSPG4 DAAM2 NEXN	6.04e-06	181	169	7	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_1\|COVID-19_Severe / Disease condition and Cell class	WASHC2C RETREG2 MATR3 WASHC2A FBH1 VCAN ATP5F1A	6.04e-06	181	169	7	0d07a67e8ee3bca687b378afbc4044434e63556d
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 CNTN6 CELSR1 LMO7 UTRN AGRN	6.04e-06	181	169	7	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	6.27e-06	182	169	7	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PERM1 STIL DNAAF3 NCAPG MKI67 PNCK ESPL1	6.27e-06	182	169	7	39f9b3eb22293cc27c6e175702c77d1eeb24fdc9
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 HHIP TC2N LMO7 TMEM163	6.27e-06	182	169	7	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	Control-T/NK_proliferative\|Control / Disease group and Cell class	STIL ENO4 NCAPG ANLN MKI67 FBXO43 ESPL1	6.50e-06	183	169	7	09c2b4e630f1c338f02c1242e3598e870d6b0a28
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 CNTN6 CELSR1 LMO7 TNKS1BP1 UTRN	6.73e-06	184	169	7	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 HHIP CELSR1 LMO7 PIP5K1B TMEM163	6.73e-06	184	169	7	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR MATR3 KAT6A USP8 SETD2 UTRN THRAP3	6.73e-06	184	169	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	MATR3 AGGF1 MYO15B ANLN UTRN CNOT2 PCNT	6.73e-06	184	169	7	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PSD KCNK12 STIL NCAPG ANLN MKI67 ESPL1	6.97e-06	185	169	7	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 PLEKHG2 CLMN CSPG4 PIP5K1B DAAM2 UTRN	6.97e-06	185	169	7	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 HHIP CELSR1 LMO7 PIP5K1B TMEM163	6.97e-06	185	169	7	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 HHIP TC2N LMO7 TMEM163	6.97e-06	185	169	7	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 PLEKHG2 CLMN CSPG4 PIP5K1B DAAM2 UTRN	6.97e-06	185	169	7	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 CNTN6 CELSR1 TC2N LMO7 UTRN	7.22e-06	186	169	7	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 LAMA5 CNTN6 CELSR1 LMO7 AGRN	7.22e-06	186	169	7	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCC4 MATR3 ATP10B ARFGEF3 HHIP TC2N TMEM163	7.22e-06	186	169	7	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 LAMA5 CNTN6 CELSR1 LMO7 AGRN	7.48e-06	187	169	7	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 HHIP CELSR1 TC2N LMO7 TMEM163	7.48e-06	187	169	7	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	AT1_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MROH2A LAMA3 LAMA5 CNTN6 AATK LMO7 AGRN	7.48e-06	187	169	7	f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP10B MYO15B ANLN VCAN DAAM2 FAM124A PLXNB1	7.48e-06	187	169	7	97e520705491c8f52a32025311a9fa7b9176979a
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 CNTN6 CELSR1 LMO7 TNKS1BP1 UTRN	7.48e-06	187	169	7	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP10B NEK3 ANLN CLMN VCAN DAAM2 PLXNB1	7.75e-06	188	169	7	60242c29c7f16c94a84685d3bc4ed93a66e70152
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 LAMA5 CNTN6 CELSR1 LMO7 AGRN	7.75e-06	188	169	7	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNA1C AGGF1 CLOCK RYR2 KIF13A CNOT2	7.75e-06	188	169	7	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNA1C AGGF1 CLOCK RYR2 KIF13A CNOT2	7.75e-06	188	169	7	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNA1C AGGF1 CLOCK RYR2 KIF13A CNOT2	7.75e-06	188	169	7	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHROOM3 LAMA3 CNTN6 CELSR1 TC2N LMO7	7.75e-06	188	169	7	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SHROOM3 LAMA3 ARFGEF3 CELSR1 LMO7 PIP5K1B TMEM163	7.75e-06	188	169	7	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP10B ANLN CLMN VCAN CSPG4 DAAM2 KIF13A	7.75e-06	188	169	7	d9692b6048d9b85524a07a1807bdd4757731c151
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BNC2 FLNC HHIP CSPG4 DAAM2 PNCK NEXN	7.75e-06	188	169	7	879de94924de978478696fc7838e05a4d795b905
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BNC2 FLNC HHIP CSPG4 DAAM2 PNCK NEXN	8.02e-06	189	169	7	ab7ece0a517499b70b7754720d3e434765363af6
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNA1C BNC2 RYR2 HHIP DAAM2 NEXN	8.02e-06	189	169	7	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PSD RYR2 ARFGEF3 KCNJ9 BSN UNC80 MAPK8IP2	8.30e-06	190	169	7	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 LAMA5 CNTN6 LMO7 PIP5K1B NEXN	8.30e-06	190	169	7	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CABP1 CACNA1C LAMA5 RYR2 CSPG4 DAAM2 NEXN	8.59e-06	191	169	7	8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	8.59e-06	191	169	7	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH3 BARD1 STIL NCAPG MKI67 FAM124A ESPL1	8.59e-06	191	169	7	c8b99bd3a30c81ee4deba9cbf0196920ab3ab550
ToppCell	Control-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	CACNA1C LRCH2 LAMA5 CLMN CSPG4 DAAM2 NEXN	8.59e-06	191	169	7	2da83c493e60ad0278848957645277d76737a188
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LRCH2 RYR2 CLMN CSPG4 PIP5K1B DAAM2 UTRN	8.59e-06	191	169	7	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	10x5'v1-week_14-16-Hematopoietic-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ABCC4 TESPA1 RYR2 DNAAF3 TC2N TMEM163 NEXN	8.59e-06	191	169	7	7edc22e7e70697fb22690699efb352577162709b
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 ARFGEF3 CELSR1 LMO7 PIP5K1B TMEM163	8.59e-06	191	169	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CABP1 CACNA1C LAMA5 PERM1 RYR2 CSPG4 NEXN	8.59e-06	191	169	7	60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 ARFGEF3 CELSR1 LMO7 PIP5K1B TMEM163	8.89e-06	192	169	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CABP1 CACNA1C TRIL CSPG4 DAAM2 PNCK NEXN	8.89e-06	192	169	7	3617d2bc7e33d981f3ec349e9962d8d4bd822fbd
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CABP1 CACNA1C AATK CSPG4 DAAM2 PNCK PLXNB1	8.89e-06	192	169	7	eb9a0b3d32f90f8b95905c740aab21639dae5cbd
ToppCell	Dividing_Macrophages-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	8.89e-06	192	169	7	741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	LAMA3 LAMA5 CNTN6 AATK LMO7 NEXN AGRN	8.89e-06	192	169	7	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	BARD1 STIL NCAPG ANLN MKI67 FBXO43 ESPL1	9.19e-06	193	169	7	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 LAMA3 ARFGEF3 CELSR1 TC2N LMO7 TMEM163	9.19e-06	193	169	7	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNK12 RPH3A ARFGEF3 SKOR1 BSN UNC80 MAPK8IP2	9.19e-06	193	169	7	5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4
Disease	familial nephrotic syndrome (is_implicated_in)	LAMA5 DAAM2	3.07e-05	2	164	2	DOID:2590 (is_implicated_in)
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CACNA1C CACNA1S UTRN SNTB2	4.72e-05	36	164	4	DOID:11723 (implicated_via_orthology)
Disease	Colorectal Carcinoma	FLNC ABCC4 ABCA4 PEX5L TXNRD1 HHIP NCAPG TIAM1 LMO7 MKI67 MCRS1 SNRNP200 EPHA1	1.60e-04	702	164	13	C0009402
Disease	hypertrophic cardiomyopathy	MATR3 TXNRD1 STRN TNKS1BP1 SYMPK	1.66e-04	92	164	5	EFO_0000538
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1S	1.83e-04	4	164	2	DOID:0060173 (implicated_via_orthology)
Disease	Adenoid Cystic Carcinoma	KAT6A CNTN6 SETD2 VCAN ESPL1	2.45e-04	100	164	5	C0010606
Disease	cortical thickness, neuroimaging measurement	ENO4 DNAAF3 STRN VCAN DAAM2	3.82e-04	110	164	5	EFO_0004346, EFO_0004840
Disease	Colorectal Neoplasms	FLNC ABCC4 ABCA4 TXNRD1 HHIP MKI67 EPHA1	9.47e-04	277	164	7	C0009404
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH3	1.34e-03	10	164	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH3	1.34e-03	10	164	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH3	1.34e-03	10	164	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH3	1.34e-03	10	164	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH3	1.34e-03	10	164	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH3	1.34e-03	10	164	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH3	1.34e-03	10	164	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH3	1.34e-03	10	164	2	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH3	1.95e-03	12	164	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH3	1.95e-03	12	164	2	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH3	2.30e-03	13	164	2	DOID:397 (implicated_via_orthology)
Disease	sphingomyelin 18:1 measurement	CACNA1C TNKS1BP1	2.30e-03	13	164	2	EFO_0010394
Disease	Disease Exacerbation	NDUFS1 CLCN3 MKI67 SYMPK RAD23A	2.34e-03	165	164	5	C0235874
Disease	myopathy (implicated_via_orthology)	MYH2 MYH3 FLNC	2.43e-03	48	164	3	DOID:423 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH3	3.07e-03	15	164	2	DOID:0050646 (implicated_via_orthology)
Disease	response to irinotecan	ABCC4 TRIL	3.07e-03	15	164	2	EFO_0004829
Disease	C-X-C motif chemokine 10 measurement	MYH2 SHROOM3 GLDC CCDC158	3.25e-03	109	164	4	EFO_0008056
Disease	response to acetylsalicylate	DNAAF3 SETD2	3.50e-03	16	164	2	GO_1903492
Disease	plasma beta-amyloid 1-40 measurement	DNAAF3 RNF214	3.95e-03	17	164	2	EFO_0005659
Disease	Moyamoya Disease	RNF213 PCNT	3.95e-03	17	164	2	C0026654
Disease	Hypertrophic Cardiomyopathy	CACNA1C NDUFS1 RYR2	3.96e-03	57	164	3	C0007194

Protein segments in the cluster

Peptide	Gene	Start	Entry
SDFGLTRLLDDFDGT	EPHA1	766	P21709
GEIDLLASGSLTESE	BARD1	256	Q99728
ESDTELLFSGLGSGE	VCAN	2246	P13611
ALRSTDGDSGSEDLV	CSPG4	1496	Q6UVK1
EETLADLGLSSFGIS	ABCA4	1251	P78363
SSRESDAGSDEGILL	BNC2	976	Q6ZN30
ELDDNAGLSRSETGS	ADGRB3	1391	O60242
LFGETARSIESTLDD	AGRN	1161	O00468
RLSLDSQEGDSGLDS	ARHGEF11	211	O15085
EDTSLEGSSLAESLR	AGGF1	181	Q8N302
GESTASLDSIVRDEG	CELSR1	2756	Q9NYQ6
STSDDASRLEAGGET	ANO4	86	Q32M45
TGGLLQVDDDSSLSE	ANKRD26	641	Q9UPS8
TNGDGEISTSELREA	CABP1	316	Q9NZU7
LESGSGTSLEEALEA	ATP10B	691	O94823
GADTSVDLEETGRVL	ATP5F1A	61	P25705
RSSLSLEEADSEVEG	C9orf152	86	Q5JTZ5
SSGREEDAASTLVTG	RAD23A	146	P54725
SSFLDSDELERTGID	RBM39	336	Q14498
SDELERTGIDLGTTG	RBM39	341	Q14498
GSDDIFGLSTDSLSR	RAB3IP	146	Q96QF0
TDLSVGFDTGDDRLF	KCNJ9	226	Q92806
TGTESASEEGDDSLL	NEXN	156	Q0ZGT2
ETFLSLEDGLGSSDS	MSGN1	6	A6NI15
TSGSDIIDLAGDTVR	CAPN15	316	O75808
GEFDDLVSALRSGEV	DAAM2	1021	Q86T65
EAELRLTLTALDGGS	PCDHB13	206	Q9Y5F0
AALLESGSSVGDETD	MATR3	666	P43243
EESGLRSAEGSVLDL	MAGEC3	331	Q8TD91
SGSESEEAELSLSLA	LYSMD2	31	Q8IV50
LEEASDTGSGRIALA	LAMA3	1636	Q16787
AESGDSLGSEDRDLL	ANLN	656	Q9NQW6
ISETELELSSDGGSS	MAPK8IP2	271	Q13387
NLEEDDTATSGRGLA	BSN	856	Q9UPA5
ETDVDTGLRLSSSDL	FAM124A	411	Q86V42
STLLSGDGDSAELEG	PLXNB1	866	O43157
DSDAEGRRLSGELIS	KCNK12	356	Q9HB15
ATTLAGGRDSTESEF	MUC19	6391	Q7Z5P9
DRDSGRNGEVSLDIS	PCDHGC5	376	Q9Y5F6
GDIFTTETSIDREGL	PCDH1	106	Q08174
EISERLEEAGGATSA	MYH2	1151	Q9UKX2
ADGSDLISTDAEQRG	PEX5L	141	Q8IYB4
TEGQSFSSLDEEALG	PIP5K1B	441	O14986
SEDSTTGEELLLSEG	NFIL3	36	Q16649
VEASDLSLSLTGDDG	DCAF8	41	Q5TAQ9
EFTIDARDAGEGLLT	FLNC	1561	Q14315
TLRGGREGFESDTDS	LMO7	266	Q8WWI1
LLERTNSGFEESDSG	ANKRD44	551	Q8N8A2
LEDLAGFTELSETSG	MKI67	2676	P46013
LRADDGAGEFSTSVT	LAMA5	3581	O15230
VESDESLGGLSAALR	IRAK1	586	P51617
LESSEEGGSAEERRL	C17orf75	16	Q9HAS0
VLVDDSELGGAGSSR	PTGDR2	326	Q9Y5Y4
LAITDLESGREDEAG	PCNT	221	O95613
EDELEESRGTLGSRA	CRACDL	76	Q6NV74
LTSSLTAEDDRGGSV	NEK3	381	P51956
AGIATTGTEDSDDAL	PIPSL	731	A2A3N6
DTSGSELSEGELEKR	PRPF40A	931	O75400
SGDTAFDRDILGSVS	PNCK	271	Q6P2M8
EDGDLTVIGDRGTTL	ABCC4	521	O15439
GGLEVDLDSLTTTED	MYO15B	1296	Q96JP2
AISEGQLSSDESGDL	FBXO43	416	Q4G163
SSSSEEGYLERIDGL	KAT6A	376	Q92794
GDRAVLRGFSESSEE	KAT6A	976	Q92794
SAITDVEGGLSDALR	BOD1L1	2086	Q8NFC6
GEFDDLVSALRSGEV	DAAM1	1031	Q9Y4D1
SSIGSVLDDADREVS	CEFIP	16	Q711Q0
SFEILRGSDGEDSAS	ESPL1	1501	Q14674
SRLSAESGETDQDAG	FBH1	171	Q8NFZ0
AVGGRDDTTELSSAE	KLHL20	511	Q9Y2M5
DEDRGSGAFSLETIA	BRME1	121	Q0VDD7
EDLELRRDSGSAGTQ	CACNA1C	1871	Q13936
GIEADDESLLRTSNG	DNAAF3	286	Q8N9W5
VRSGSGSIDDDRDSL	GIGYF2	271	Q6Y7W6
DIESETGSTGALETR	C2CD2L	616	O14523
LSLDEGGSDTESLYE	CACNA1S	386	Q13698
AVGELGTESSDNLDR	CEP126	11	Q9P2H0
GIESVLSDFDDDTGL	ARFGEF3	1436	Q5TH69
SGIGSIFLSASELED	IFIT3	451	O14879
SLEVEEAGESSSRLG	AKNA	131	Q7Z591
LIEIRTVSDGGDGSS	CNTN6	971	Q9UQ52
SGTASRSEDEESLAG	MCRS1	16	Q96EZ8
GSTEGESSDDSLVDL	ENO4	521	A6NNW6
ESSDDSLVDLAVGLG	ENO4	526	A6NNW6
SDEEVDSVLFGSLRG	HLTF	51	Q14527
IDGDGTALFEITSDA	CDH8	316	P55286
TEEDGRTSLGALEDR	CCDC158	926	Q5M9N0
AGIATTGTEDSDDAL	PSMD4	246	P55036
LDEDGSLDGNSDLTI	RYR2	2011	Q92736
GLASGDELLSSDIDQ	PERM1	31	Q5SV97
SLISLIEDFGSLGES	PPRC1	101	Q5VV67
IEDFGSLGESRLSLE	PPRC1	106	Q5VV67
TDASESIRALFGTDG	NME7	186	Q9Y5B8
SDLETEGTDGLGELV	LRRC74B	41	Q6ZQY2
DRALEEAGSSGILSL	LRCH2	81	Q5VUJ6
LESSLDSLGDVFLDS	NUMA1	1786	Q14980
EAELRLTLTALDGGS	PCDHB8	206	Q9UN66
ILAELREGDVGSSFD	MROH2A	1456	A6NES4
LLAARSENEGTSDGE	KIF13A	1326	Q9H1H9
EDFGLRDTLSIASTD	MIGA1	311	Q8NAN2
ISSDEEELRTLGSSG	RUNDC3B	231	Q96NL0
TDRGEDGLTLDVTGT	SKOR1	836	P84550
STSEGLLGDLDTEIS	UTRN	1571	P46939
LVTSEEGDNESRSAG	STRN	291	O43815
DSDLEEFVRSHGLGS	UVSSA	286	Q2YD98
DSDEATTLGALEFSL	RPH3A	386	Q9Y2J0
YTRSLGDVDDGDTVT	GFM2	96	Q969S9
SELDSTERLALGSTD	PSD	531	A5PKW4
FSEAATGEESLLSEG	SLA2	226	Q9H6Q3
TGEESLLSEGLRESL	SLA2	231	Q9H6Q3
SLDTITLSGDERDFG	TC2N	211	Q8N9U0
AELRALEEGDGSVSG	FNBP4	416	Q8N3X1
DGDDVLTVTETSRGL	AATK	461	Q6ZMQ8
DLEDDEVRDLGSTGT	NIN	1146	Q8N4C6
ASEIAGVDDLGTTGR	NDUFS1	186	P28331
RSEAEDSSDESLGIV	PNMA8B	191	Q9ULN7
AREELLAEFGSGTLD	EPPK1	3616	P58107
AREELLAEFGSGTLD	EPPK1	4686	P58107
SDEEASILESGGFSV	RETREG2	311	Q8NC44
ASTFLGEVASGDDRS	INPPL1	1106	O15357
VLSGLGEDASNEERS	SHROOM3	1861	Q8TF72
ELSERLEEAGGVTST	MYH3	1146	P11055
LGSTEDGDGTDDFLT	SURF2	181	Q15527
SESGELLDAGDVFVS	NUAK2	466	Q9H093
SDFTGSVLRLDVDTD	HHIP	386	Q96QV1
SEGLDEEIGFTLSED	URB1	761	O60287
LTSDESTLIEDGGAR	SERINC1	346	Q9NRX5
STLIEDGGARSDGSL	SERINC1	351	Q9NRX5
SLETLGSHSEEGLDF	CLMN	696	Q96JQ2
SSIVDRDDSSIFDGL	CLOCK	11	O15516
LSDFLDSEVSELRTG	NCAPG	696	Q9BPX3
DSEVSELRTGAAEGL	NCAPG	701	Q9BPX3
FRGESSEELSHGLAE	CLRN3	56	Q8NCR9
EESGSEGLDELIFAR	CNDP2	166	Q96KP4
SASSDEELLDGAGVI	CLCN3	21	P51790
TDGSENVTGLDLSDF	CNOT2	216	Q9NZN8
DRGEGSISSLADILV	TEX44	281	Q53QW1
TEDGRALEGTLSELA	TXNRD1	101	Q16881
ELGGSDVSILDTTRL	RNF213	3521	Q63HN8
DVASTAGEEGDTSLR	RNF214	111	Q8ND24
LGSLTADEDEEGVTL	STIL	81	Q15468
TLLSTGSLEAGDSER	USP19	891	O94966
EREESTTGFDKSRLG	THRAP3	801	Q9Y2W1
ELGDSLTFGSAISES	ZNF197	346	O14709
RSSLSGLADGVEDLL	UNC80	1091	Q8N2C7
GLDNGTISEFILSED	WDFY2	86	Q96P53
FADSGIEGATTDTDL	TIAM1	331	Q13009
RLGNGVSDDLSSEED	PHTF1	266	Q9UMS5
ETIGSLDTEADSGLS	SARG	56	Q9BW04
REDGSLEIGDTTTFS	UBA7	231	P41226
ESEGISSEAGLEIDS	TPR	2271	P12270
EEETVASGEESLGFL	SOX12	241	O15370
SEEIESAFRALSSEG	SPTAN1	2406	Q13813
EDDDAEGLSSRLSGT	SNX21	46	Q969T3
GSLELSAEGVSRDSS	TBC1D16	211	Q8TBP0
RESAASGLGGLLEEE	TNKS1BP1	1471	Q9C0C2
ESSDSATLRELRGDT	TRIL	641	Q7L0X0
LNGSAELSTSGELED	ZNF646	351	O15015
ELSTSGELEDSGLEE	ZNF646	356	O15015
SGASGSSFEELDLEG	TEX264	266	Q9Y6I9
LGELSSEEGSVGSDR	WASHC2C	201	Q9Y4E1
RVSLLFEDDVDSGGS	WASHC2C	686	Q9Y4E1
SQEIGLASLGASDED	TPH2	336	Q8IWU9
GIFLGSESDEDSVRT	SETD2	316	Q9BYW2
SGLTEAALLDSSLEG	SYMPK	1211	Q92797
DTLGLFLREGSASTE	SNRNP200	746	O75643
LGELSSEEGSVGSDR	WASHC2A	201	Q641Q2
RVSLLFEDDVDSGGS	WASHC2A	686	Q641Q2
GVASGEEDFTLDVSL	ZBED6	191	P86452
GTSFEDDLTLGAEAT	TESPA1	91	A2RU30
GRSILLGSGDSEVTE	ZBTB2	481	Q8N680
ELLEDLENSSSAGGI	PLEKHG2	161	Q9H7P9
AELSGESLSLTGDAA	SNTB2	41	Q13425
SDGLEDRGLLESSTR	TMEM163	61	Q8TC26
SGILRTGTFREDTDD	USP8	611	P40818
DIVSRGSTADLDGLL	TRPV4	156	Q9HBA0
TVIRAESLDGGDTSS	ZFYVE16	461	Q7Z3T8
QGLSDDDILRDSGSD	ZC3H18	21	Q86VM9
RLFEDGTLGISLDET	GLDC	461	P23378
GDGRFIETSSAADLE	KTN1-AS1	16	Q86SY8
ASARTAAEGEGTLES	LRFN4	391	Q6PJG9
LESGDRIRTGTTLDE	MYOM3	1261	Q5VTT5